J. Ndiaye, F. B. Gueye, A. Tine, R. Ndiaye, D. Tchania et al., Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial, Malaria Journal, vol.10, issue.1, p.237, 2011.
DOI : 10.1111/j.1365-3156.2008.02119.x

S. Thiam, M. Thior, F. B. Diouf, M. Diouf, M. Diallo et al., Major Reduction in Anti-Malarial Drug Consumption in Senegal after Nation-Wide Introduction of Malaria Rapid Diagnostic Tests, PLoS ONE, vol.83, issue.4, p.18419, 2011.
DOI : 10.1371/journal.pone.0018419.t002

B. Fall, A. Pascual, F. Sarr, N. Wurtz, V. Richard et al., Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study, Malaria Journal, vol.12, issue.1, p.107, 2013.
DOI : 10.1016/S0140-6736(06)68264-0
URL : https://hal.archives-ouvertes.fr/inserm-00803938

D. Van-tyne, B. Dieye, C. Valim, R. Daniels, D. Sène et al., Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal, Malaria Journal, vol.12, issue.1, p.441, 2013.
DOI : 10.1073/pnas.1211205110

C. Lambros and J. Vanderberg, Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture, The Journal of Parasitology, vol.65, issue.3, pp.418-438, 1979.
DOI : 10.2307/3280287

H. Bogreau, F. Renaud, H. Bouchiba, P. Durand, S. Assi et al., Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas, Am J Trop Med Hyg, vol.74, pp.953-962, 2006.

M. Henry, I. Diallo, J. Bordes, S. Ka, B. Pradines et al., Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates, Am J Trop Med Hyg, vol.75, pp.146-51, 2006.

A. Pascual, L. Basco, E. Baret, R. Amalvict, D. Travers et al., Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs, Malaria Journal, vol.10, issue.1, p.8, 2011.
DOI : 10.1186/1475-2875-10-8

L. Nagard, H. Vincent, C. Mentré, F. , L. Bras et al., Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression, Computer Methods and Programs in Biomedicine, vol.104, issue.1, pp.10-18, 2011.
DOI : 10.1016/j.cmpb.2010.08.003
URL : https://hal.archives-ouvertes.fr/inserm-00521869

B. Fall, S. Diawara, K. Sow, E. Baret, B. Diatta et al., Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs, Malaria Journal, vol.10, issue.1, p.310, 2011.
DOI : 10.1128/AAC.45.6.1746-1750.2001

P. Drame, V. Machault, A. Diallo, S. Cornélie, A. Poinsignon et al., IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, S??n??gal, Malaria Journal, vol.11, issue.1, p.72, 2012.
DOI : 10.1016/j.ibmb.2006.11.005

J. Trape, A. Tall, C. Sokhna, B. Ly, A. Diagne et al., The rise and fall of malaria in a west African rural community, Dielmo, Senegal, from 1990 to 2012: a 22 year longitudinal study, The Lancet Infectious Diseases, vol.14, issue.6, pp.476-88, 2014.
DOI : 10.1016/S1473-3099(14)70712-1

R. Jambou, E. Legrand, M. Niang, N. Khim, P. Lim et al., Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6, The Lancet, vol.366, issue.9501, pp.1960-1963, 2005.
DOI : 10.1016/S0140-6736(05)67787-2
URL : https://hal.archives-ouvertes.fr/pasteur-00590989

M. Gari-toussaint, B. Pradines, V. Mondain, A. Keundjian, P. Dellamonica et al., Sénégal et paludisme. Echec prophylactique vrai de la méfloquine, Presse Med, vol.31, p.1136, 2002.

I. Hatin, J. Trape, F. Legros, J. Bauchet, L. Bras et al., Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area in Senegal, Bull World Health Organ, vol.70, pp.363-370, 1992.

C. Sokhna, J. Molez, P. Ndiaye, B. Sane, and J. Trape, Tests in vivo de chimiosensibilite de Plasmodium falciparum à la chloroquine au Sénégal: évolution de la résistance et estimation de l'efficacité thérapeutique, Bull Soc Pathol Exot, vol.90, pp.83-92, 1997.

S. Thomas, O. Ndir, T. Dieng, S. Mboup, D. Wypij et al., In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal, Am J Trop Med Hyg, vol.66, pp.474-80, 2002.

O. Sarr, A. Myrick, J. Daily, B. Diop, T. Dieng et al., In vivo and in vitro analysis of chloroquine resistance in Plasmodium falciparum isolates from Senegal, Parasitology Research, vol.57, issue.Pt 3, pp.136-176, 2005.
DOI : 10.1007/s00436-005-1406-7

O. Ly, P. Gueye, A. Deme, T. Dieng, A. Badiane et al., Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8??years after cessation of chloroquine use in Pikine, Senegal, Parasitology Research, vol.72, issue.8, pp.1541-1547, 2012.
DOI : 10.1007/s00436-012-2994-7

O. Sarr, A. Ahouidi, O. Ly, J. Daily, D. Ndiaye et al., Mutations in PFCRT K76T do not correlate with sulfadoxine???pyrimethamine???amodiaquine failure in Pikine, Senegal, Parasitology Research, vol.73, issue.4, pp.765-774, 2008.
DOI : 10.1007/s00436-008-1038-9

M. Gharbi, J. Flegg, V. Hubert, E. Kendjo, J. Metcalf et al., Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000???2011, Malaria Journal, vol.12, issue.1, p.35, 2000.
DOI : 10.1016/j.pt.2005.12.011
URL : https://hal.archives-ouvertes.fr/inserm-00795004

L. Ministère-de and . Santé-et-de-la-prévention-médicale, Enquête nationale sur le paludisme au Sénégal, 2006.

L. Ministère-de and . Santé-et-de-la-prévention-médicale, Enquête nationale sur le paludisme au Sénégal, 2008.

N. Noranate, R. Durand, A. Tall, L. Marrama, A. Spiegel et al., Rapid Dissemination of Plasmodium falciparum Drug Resistance Despite Strictly Controlled Antimalarial Use, PLoS ONE, vol.2, issue.1, p.139, 2007.
DOI : 10.1371/journal.pone.0000139.s003

P. Brasseur, R. Guiguemde, S. Diallo, V. Guiyedi, M. Kombila et al., Amodiaquine remains effective for treating uncomplicated malaria in West and Central Africa, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.93, issue.6, pp.645-50, 1999.
DOI : 10.1016/S0035-9203(99)90083-4

J. Ndiaye, M. Randrianarivelojosia, I. Sagara, P. Brasseur, I. Ndiaye et al., Randomized, multicentre assessment of the efficacy and safety of ASAQ ??? a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria, Malaria Journal, vol.8, issue.1, p.125, 2009.
DOI : 10.1186/1475-2875-8-125

A. Dondorp, F. Nosten, P. Yi, D. Das, A. Phyo et al., Malaria, New England Journal of Medicine, vol.361, issue.5, pp.455-67, 2009.
DOI : 10.1056/NEJMoa0808859
URL : https://hal.archives-ouvertes.fr/hal-01199794

H. Noedl, Y. Se, K. Schaecher, B. Smith, D. Socheat et al., Evidence of Artemisinin-Resistant Malaria in Western Cambodia, New England Journal of Medicine, vol.359, issue.24, pp.2619-2639, 2008.
DOI : 10.1056/NEJMc0805011

A. Phyo, S. Nkhoma, K. Stepniewska, E. Ashley, S. Nair et al., Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study, The Lancet, vol.379, issue.9830, pp.1960-1966, 2012.
DOI : 10.1016/S0140-6736(12)60484-X

E. Ashley, M. Dhorda, R. Fairhurst, C. Amaratunga, P. Lim et al., Malaria, New England Journal of Medicine, vol.371, issue.5, pp.411-434, 2014.
DOI : 10.1056/NEJMoa1314981
URL : https://hal.archives-ouvertes.fr/inserm-00854378

B. Pradines, A. Tall, C. Rogier, A. Spiegel, J. Mosnier et al., In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs, Tropical Medicine and International Health, vol.82, issue.3, pp.265-70, 2002.
DOI : 10.1016/S0764-4469(98)80009-7

B. Pradines, M. Mamfoumbi, M. Tall, A. Sokhna, C. Koeck et al., In Vitro Activity of Tafenoquine against the Asexual Blood Stages of Plasmodium falciparum Isolates from Gabon, Senegal, and Djibouti, vitro activity of tafenoquine against the asexual blood stages of Plasmodium falciparum isolates from Gabon, Senegal, and Djibouti, pp.3225-3231, 2006.
DOI : 10.1128/AAC.00777-06

D. Ndiaye, V. Patel, A. Demas, M. Leroux, O. Ndir et al., A Non-Radioactive DAPI-based High-Throughput In Vitro Assay to Assess Plasmodium falciparum Responsiveness to Antimalarials--Increased Sensitivity of P. falciparum to Chloroquine in Senegal, American Journal of Tropical Medicine and Hygiene, vol.82, issue.2, pp.228-258, 2010.
DOI : 10.4269/ajtmh.2010.09-0470

B. Witkowski, C. Amaratunga, N. Khim, S. Sreng, P. Chim et al., Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies, The Lancet Infectious Diseases, vol.13, issue.12, pp.1043-1052, 2013.
DOI : 10.1016/S1473-3099(13)70252-4
URL : https://hal.archives-ouvertes.fr/pasteur-00863935

B. Witkowski, N. Khim, P. Chim, S. Kim, S. Ke et al., Reduced Artemisinin Susceptibility of Plasmodium falciparum Ring Stages in Western Cambodia, Antimicrobial Agents and Chemotherapy, vol.57, issue.2, pp.914-937, 2013.
DOI : 10.1128/AAC.01868-12

F. Ariey, B. Witkowsky, C. Amaratunga, J. Beghain, A. Langlois et al., A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, vol.10, issue.7481, pp.50-55, 2014.
DOI : 10.1038/nature12876
URL : https://hal.archives-ouvertes.fr/pasteur-00921203

C. Amaratunga, B. Witkowski, N. Khim, D. Menard, and R. Fairhurst, Artemisinin resistance in Plasmodium falciparum, The Lancet Infectious Diseases, vol.14, issue.6, pp.449-50, 2014.
DOI : 10.1016/S1473-3099(14)70777-7
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573664

W. Yavo, F. B. Kuete, T. Djohan, V. Oga, S. Kassi et al., Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa, Malaria Journal, vol.10, issue.1, p.198, 2011.
DOI : 10.1016/j.trstmh.2007.05.018

A. Yeka, J. Tibenderana, J. Achan, D. 'alessandro, U. Talisuna et al., Efficacy of Quinine, Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine as Rescue Treatment for Uncomplicated Malaria in Ugandan Children, PLoS ONE, vol.379, issue.9, p.53772, 2013.
DOI : 10.1371/journal.pone.0053772.s005

A. Agarwal, M. Mcmorrow, P. Onyango, K. Otieno, C. Odero et al., A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya, Malaria Journal, vol.12, issue.1, p.254, 2013.
DOI : 10.1186/1475-2875-10-209

A. Pascual, M. Madamet, L. Bertaux, R. Amalvict, N. Benoit et al., In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene, Malaria Journal, vol.12, issue.1, p.431, 2013.
DOI : 10.1128/AAC.01793-10
URL : https://hal.archives-ouvertes.fr/inserm-00911243

A. Pascual, P. Parola, F. Benoit-vical, F. Simon, D. Malvy et al., Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum, Malaria Journal, vol.11, issue.1, p.45, 2012.
DOI : 10.1128/AAC.49.12.5127-5128.2005
URL : https://hal.archives-ouvertes.fr/pasteur-00836167

O. Brandicourt, P. Druilhe, F. Diouf, P. Brasseur, P. Turk et al., Decreased sensitivity to chloroquine and quinine of some Plasmodium falciparum strains from Senegal in september 1984, Am J Trop Med Hyg, vol.35, pp.717-738, 1986.

B. Pradines, A. Tall, D. Parzy, A. Spiegel, T. Fusai et al., In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents., Journal of Antimicrobial Chemotherapy, vol.42, issue.3, pp.333-342, 1998.
DOI : 10.1093/jac/42.3.333

B. Pradines, A. Tall, F. Ramiandrasoa, A. Spiegel, C. Sokhna et al., In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum, Journal of Antimicrobial Chemotherapy, vol.57, issue.6, pp.1093-1102, 2006.
DOI : 10.1093/jac/dkl117

T. Jelinek, P. Schelbert, T. Loscher, and D. Eichenlaub, Quinine resistant falciparum malaria acquired in east Africa, Trop Med Parasitol, vol.46, pp.38-40, 1995.

F. Palmieri, N. Petrosillo, M. Paglia, A. Conte, D. Goletti et al., Genetic Confirmation of Quinine-Resistant Plasmodium falciparum Malaria Followed by Postmalaria Neurological Syndrome in a Traveler from Mozambique, Journal of Clinical Microbiology, vol.42, issue.11, pp.5424-5430, 2004.
DOI : 10.1128/JCM.42.11.5424-5426.2004

B. Pradines, T. Pistone, K. Ezzedine, S. Briolant, L. Bertaux et al., Quinine-Resistant Malaria in Traveler Returning from Senegal, 2007, Emerging Infectious Diseases, vol.16, issue.3, pp.546-554, 2007.
DOI : 10.3201/eid1603.091669

A. Pascual, M. Henry, S. Briolant, S. Charras, E. Baret et al., In Vitro Activity of Proveblue (Methylene Blue) on Plasmodium falciparum Strains Resistant to Standard Antimalarial Drugs, vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs, pp.2472-2476, 2011.
DOI : 10.1128/AAC.01466-10

J. Dormoi, A. Pascual, S. Briolant, R. Amalvict, S. Charras et al., Proveblue (Methylene Blue) as an Antimalarial Agent: In Vitro Synergy with Dihydroartemisinin and Atorvastatin, Antimicrobial Agents and Chemotherapy, vol.56, issue.6, pp.3467-3476, 2012.
DOI : 10.1128/AAC.06073-11

J. Dormoi, S. Briolant, C. Desgrouas, and B. Pradines, Efficacy of Proveblue (Methylene Blue) in an Experimental Cerebral Malaria Murine Model, Antimicrobial Agents and Chemotherapy, vol.57, issue.7, pp.3412-3416, 2013.
DOI : 10.1128/AAC.02381-12

J. Dormoi, S. Briolant, C. Desgrouas, and B. Pradines, Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model, Malaria Journal, vol.12, issue.1, p.127, 2013.
DOI : 10.1186/1475-2875-11-316
URL : https://hal.archives-ouvertes.fr/inserm-00818382

J. Dormoi and B. Pradines, Dose Responses of Proveblue Methylene Blue in an Experimental Murine Cerebral Malaria Model, Antimicrobial Agents and Chemotherapy, vol.57, issue.8, pp.4080-4081, 2013.
DOI : 10.1128/AAC.00634-13

O. Ademowo, C. Nneji, and A. Adedapo, In vitro antimalarial activity of methylene blue against field isolates of Plasmodium falciparum from children in Southeast Nigeria, Indian J Med Res, vol.126, pp.45-54, 2007.

J. Okombo, S. Kiara, L. Mwai, L. Pole, E. Ohuma et al., Baseline In Vitro Activities of the Antimalarials Pyronaridine and Methylene Blue against Plasmodium falciparum Isolates from Kenya, Antimicrobial Agents and Chemotherapy, vol.56, issue.2, pp.1105-1112, 2012.
DOI : 10.1128/AAC.05454-11

R. Suwanarusk, R. B. Ong, A. Sriprawat, K. Chu, C. Phyo et al., Methylene blue inhibits the asexual development of vivax malaria parasites from a region of increasing chloroquine resistance, Journal of Antimicrobial Chemotherapy, vol.70, issue.1, 2014.
DOI : 10.1093/jac/dku326

S. Adjalley, G. Jonhston, T. Li, R. Eastman, E. Ekland et al., Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue, Proceedings of the National Academy of Sciences, vol.108, issue.47, pp.1214-1237, 2011.
DOI : 10.1073/pnas.1112037108

B. Coulibaly, A. Zoungrana, F. Mockenhaupt, R. Schirmer, C. Klose et al., Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial, PLoS ONE, vol.49, issue.2, p.5318, 2009.
DOI : 10.1371/journal.pone.0005318.s002